MS vs SNDX · P/E 20, rev $41.93B vs rev $137.7M
Morgan Stanley (MS) versus Syndax Pharmaceuticals Inc (SNDX) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Latest reported MS revenue for 2026-06-30 was $41.93B. Net income was $11.15B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. SNDX currently screens at market cap $774.4M.
Not investment advice. Open the MS and SNDX stock pages for the full models.
Not investment advice.